COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and may be modified by dexamethasone
Aartik Sarma, Stephanie A. Christenson, Eran Mick, Catherine DeVoe, Thomas Deiss, Angela Oliveira Pisco, Rajani Ghale, Alejandra Jauregui, Ashley Byrne, Farzad Moazed, Natasha Spottiswoode, Pratik Sinha, Beth Shoshana Zha, Paula Hayakawa Serpa, K. Mark Ansel, Jennifer G. Wilson, Aleksandra Leligdowicz, Emily R. Siegel, Marina Sirota, Joseph L. DeRisi, Michael A. Matthay, COMET Consortium, Carolyn M. Hendrickson, Kirsten N. Kangelaris, Matthew F. Krummel, Prescott G. Woodruff, David J. Erle, Carolyn S. Calfee, Charles R. Langelier
medRxiv 2020.12.28.20248552; doi: https://doi.org/10.1101/2020.12.28.20248552